Tiziana Life Sciences Ltd (NASDAQ:TLSA) Sees Large Decrease in Short Interest

Tiziana Life Sciences Ltd (NASDAQ:TLSA) was the recipient of a significant decrease in short interest in the month of June. As of June 15th, there was short interest totalling 92,900 shares, a decrease of 48.6% from the May 31st total of 180,700 shares. Based on an average daily trading volume, of 250,900 shares, the short-interest ratio is currently 0.4 days.

Tiziana Life Sciences Trading Up 2.3 %

Tiziana Life Sciences stock traded up $0.02 during mid-day trading on Friday, hitting $0.90. 358,084 shares of the company traded hands, compared to its average volume of 168,507. The stock has a fifty day moving average price of $0.80 and a 200-day moving average price of $0.62. Tiziana Life Sciences has a one year low of $0.41 and a one year high of $1.05.

About Tiziana Life Sciences

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases.